Related Experiment Video
Updated: Feb 6, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Safety and efficacy of recanalization therapy in pediatric stroke: A systematic review and meta-analysis
Juliana T Pacheco1, Timo Siepmann2, Jessica Barlinn3
1Division of Health Care Sciences, Dresden International University, Dresden, Germany.
Insights
Evidence on acute recanalization therapies for pediatric acute ischemic stroke (AIS) is limited. Intravenous thrombolysis in children showed increased risk of intracranial hemorrhage but similar in-hospital mortality, with no data on efficacy.
Area of Science:
- Pediatric Neurology
- Neurocritical Care
- Stroke Medicine
Background:
- Acute ischemic stroke (AIS) in children is a significant concern.
- The safety and efficacy of acute recanalization therapies, including intravenous thrombolysis and endovascular therapy, in pediatric AIS are not well-established.
- Current evidence for these treatments in children is scarce.
Purpose of the Study:
- To systematically review and synthesize available evidence on the safety and efficacy of acute recanalization therapies in pediatric AIS patients.
- To evaluate outcomes of intravenous thrombolysis and endovascular therapy in children under 18 years old.
- To identify gaps in current research regarding these treatments.
Main Methods:
- A systematic review and meta-analysis of studies on pediatric AIS patients (<18 years) treated with thrombolysis or endovascular therapy.
- Searched Medline and Cochrane Library databases for eligible studies published up to August 31, 2016.
- Assessed safety outcomes (intracranial hemorrhage, mortality) and efficacy outcomes (functional status at 3-6 months).
Main Results:
- Only 3 studies with 16,987 pediatric patients met eligibility criteria; 181 received IV thrombolysis.
- No randomized trials or data on endovascular thrombectomy were found.
- IV thrombolysis was associated with an increased risk of any intracranial hemorrhage (RR=3.48) but similar in-hospital mortality compared to controls.
- Complete data on symptomatic intracranial hemorrhage and efficacy outcomes were lacking.
Conclusions:
- There is a substantial lack of high-quality data regarding the safety and efficacy of acute recanalization therapies for pediatric AIS.
- Further research, including randomized controlled trials, is urgently needed to establish optimal treatment strategies for children with AIS.
- Current evidence suggests potential risks associated with IV thrombolysis in children, necessitating cautious application.
Background And Purpose:
Safety and efficacy of intravenous (IV) thrombolysis and endovascular therapy in children with acute ischemic stroke (AIS) are unknown to date. We aimed to review and synthesize currently available evidence on these acute recanalization therapies in pediatric stroke patients.
Methods:
We performed a systematic review and meta-analysis of all available data on safety and efficacy of acute treatment including thrombolysis and endovascular therapy in pediatric AIS patients aged <18 years. We searched the electronic databases Medline and Cochrane Library for eligible studies published from the earliest date available until August 31, 2016. Safety outcomes included intracerebral hemorrhage (ICH) post-treatment and in-hospital mortality. Efficacy outcomes included functional outcome 3-6 months after index stroke.
Results:
We identified 222 records, of which 3 studies with a total of 16,987 pediatric stroke patients met our eligibility criteria of whom 181 received IV thrombolysis. No data exists from randomized trials and no data is available on endovascular thrombectomy. Risk of any ICH was increased in children receiving thrombolysis (risk ratio = 3.48, 95%CI: 1.66-7.29; p = 0.001) compared with controls, with no evidence of heterogeneity (I2 = 0%). None of the included studies reported complete data on symptomatic ICH. In-hospital mortality was similar between pediatric stroke patients treated with thrombolysis and controls (risk ratio = 1.44, 95%CI: 0.39-5.40; p = 0.586), with evidence of heterogeneity (I2 = 62%). Efficacy of revascularization therapies could not be analyzed due to lack of outcome data.
Conclusions:
Our analyses demonstrate a substantial lack of data on efficacy and safety of acute recanalization therapies in children with AIS.
Prospero Registration Information:
URL: http://www.crd.york.ac.uk/PROSPERO. Unique identifier: CRD42016047140.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Survey Safety
Self-Efficacy
Random and Systematic Errors
Directing Effect of Substituents: meta-Directing Groups

